Co-Authors
This is a "connection" page, showing publications co-authored by Alessandro Rambaldi and Fabiano Di Marco.
Connection Strength
0.933
-
Correction: Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19. Leukemia. 2021 Sep; 35(9):2734.
Score: 0.241
-
Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19. Leukemia. 2021 09; 35(9):2710-2714.
Score: 0.237
-
Endothelial injury and thrombotic microangiopathy in COVID-19: Treatment with the lectin-pathway inhibitor narsoplimab. Immunobiology. 2020 11; 225(6):152001.
Score: 0.224
-
Covid-19 and gender: lower rate but same mortality of severe disease in women-an observational study. BMC Pulm Med. 2021 Mar 20; 21(1):96.
Score: 0.058
-
Bergamo and Covid-19: How the Dark Can Turn to Light. Front Med (Lausanne). 2021; 8:609440.
Score: 0.058
-
At the peak of COVID-19 age and disease severity but not comorbidities are predictors of mortality: COVID-19 burden in Bergamo, Italy. Panminerva Med. 2021 Mar; 63(1):51-61.
Score: 0.057
-
Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19. Nat Immunol. 2021 01; 22(1):19-24.
Score: 0.057